Eli Lilly releases cheaper vials of the weight-loss drug for self-paying patients and cuts the price of two existing doses.

Hims & Hers (HIMS) made a killing last year selling an off-brand version of Ozempic, but with the drug’s shortage now over, the company will soon have to halt sales of its cheaper alternative. That ...

With Hims & Hers' main source of growth set to be extinguished, Citi analysts said its full-year guidance appeared ...

A company spokesperson said the ad was a "direct response" the Hims & Hers Super Bowl commercial. The ad features a vial that reads "compounded semaglutide" and a syringe. "Some compounded ...

The final pivot is to Hims & Hers, with its affordable “doctor-trusted” treatments, “formulated in the USA” as part of a custom treatment plan. People smile and brandish med vials as the ...

Telehealth company Hims & Hers Health (HIMS) witnessed a major dip in its stock recently despite reporting 95% revenue growth ...

Hims & Hers generated $1.5 billion in revenue in 2024, reflecting a 69% year-over-year increase. See why I rate HIMS stock a ...

Telehealth personalized care company Hims & Hers shuttered a central part of its dermatology offering, skincare brand Apostrophe, to "simplify" its dermatology offerings and operation | Hims & Hers ...

The minute-long ad from telehealth company Hims & Hers shows imagery including a scale, food including pies and cheeseburgers, and a refrigerator full of vials of Hims & Hers-labeled medications ...

Hims & Hers (HIMS) stock is sinking 20% today after ... Eli Lilly disclosed today that it had started selling 7.5 milligram and 10 milligram vials of Zepbound, its popular weight-loss drug ...

After telehealth brand Hims & Hers aired its first Super Bowl commercial ... reads text in the print ad, above a needle and vial labeled compounded semaglutide. “Bottom line: If the label ...

Hims & Hers (HIMS) made a killing last year selling ... which lets Ro offer its members cheaper Zepbound in vials rather than the standard auto-injector pens. However, he added, that there is ...